🟢 Cresco Labs is trading 5.1% up today after Q2 revenue and adjusted EBITDA beat expectations

Cresco Labs is trading 5.08% up at $0.74 as investors continue digesting its August 6, 2026 earnings release.

• Q2 revenue reached $173 million and adjusted EBITDA $40 million, beating expectations.
• Management guided for roughly flat Q3 revenue and warned higher-cost inventory could pressure gross margins.
• The rebound appears company-specific, with major indexes nearly flat.